116 related articles for article (PubMed ID: 32619110)
41. Kang-Ai Injection Inhibits Gastric Cancer Cells Proliferation through IL-6/STAT3 Pathway.
Zheng CL; Hou KZ; Wang AQ; Fang WX; Yu ST; Liang JE; Qi HY; Qu XJ; Liu YP; Che XF
Chin J Integr Med; 2022 Jun; 28(6):524-530. PubMed ID: 32648126
[TBL] [Abstract][Full Text] [Related]
42. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG
World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665
[TBL] [Abstract][Full Text] [Related]
43. Anticancer effect of YWHAZ silencing via inducing apoptosis and autophagy in gastric cancer cells.
Guo F; Jiao D; Sui GQ; Sun LN; Gao YJ; Fu QF; Jin CX
Neoplasma; 2018 Sep; 65(5):693-700. PubMed ID: 29940752
[TBL] [Abstract][Full Text] [Related]
44. Astragalus extract inhibits proliferation but enhances apoptosis in gastric cancer.
Wang Z; Dong L; Zhen Y; Wang Y; Qi D; Xu A; Meng X; Li W
Pak J Pharm Sci; 2016 Sep; 29(5):1473-1482. PubMed ID: 27731799
[TBL] [Abstract][Full Text] [Related]
45. Effects of STAT3 silencing on fate of chronic myelogenous leukemia K562 cells.
Ma LD; Zhou M; Wen SH; Ni C; Jiang LJ; Fan J; Xia L
Leuk Lymphoma; 2010 Jul; 51(7):1326-36. PubMed ID: 20497005
[TBL] [Abstract][Full Text] [Related]
46. Cardamonin exerts anti-gastric cancer activity via inhibiting LncRNA-PVT1-STAT3 axis.
Wang Z; Tang X; Wu X; Yang M; Wang W; Wang L; Tang D; Wang D
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31028131
[No Abstract] [Full Text] [Related]
47. LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer.
Zhao J; Du P; Cui P; Qin Y; Hu C; Wu J; Zhou Z; Zhang W; Qin L; Huang G
Oncogene; 2018 Jul; 37(30):4094-4109. PubMed ID: 29706652
[TBL] [Abstract][Full Text] [Related]
48. Knockdown of STAT3 by shRNA inhibits the growth of CAOV3 ovarian cancer cell line in vitro and in vivo.
Huang F; Tong X; Fu L; Zhang R
Acta Biochim Biophys Sin (Shanghai); 2008 Jun; 40(6):519-25. PubMed ID: 18535750
[TBL] [Abstract][Full Text] [Related]
49. Mitochondrial GRIM-19 as a potential therapeutic target for STAT3-dependent carcinogenesis of gastric cancer.
Huang Y; Yang M; Hu H; Zhao X; Bao L; Huang D; Song L; Li Y
Oncotarget; 2016 Jul; 7(27):41404-41420. PubMed ID: 27167343
[TBL] [Abstract][Full Text] [Related]
50. [Effects of Chinese herbal recipe Weichang'an in inducing apoptosis and related gene expression in human gastric cancer grafted onto nude mice].
Zhao AG; Yang JK; You SF; Li T; Zhao HL; Gu Y; Tang LD; Qiu JX
Zhong Xi Yi Jie He Xue Bao; 2007 May; 5(3):287-97. PubMed ID: 17498489
[TBL] [Abstract][Full Text] [Related]
51. RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells.
Tamura F; Sato Y; Hirakawa M; Yoshida M; Ono M; Osuga T; Okagawa Y; Uemura N; Arihara Y; Murase K; Kawano Y; Iyama S; Takada K; Hayashi T; Sato T; Miyanishi K; Kobune M; Takimoto R; Kato J
Gastric Cancer; 2016 Jan; 19(1):85-97. PubMed ID: 25532910
[TBL] [Abstract][Full Text] [Related]
52. IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer.
Wu X; Yang T; Liu X; Guo JN; Xie T; Ding Y; Lin M; Yang H
Tumour Biol; 2016 Apr; 37(4):5493-501. PubMed ID: 26566627
[TBL] [Abstract][Full Text] [Related]
53. STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer.
Pan YM; Wang CG; Zhu M; Xing R; Cui JT; Li WM; Yu DD; Wang SB; Zhu W; Ye YJ; Wu Y; Wang S; Lu YY
Mol Cancer; 2016 Dec; 15(1):79. PubMed ID: 27938379
[TBL] [Abstract][Full Text] [Related]
54. Cucurbitacin B inhibits gastric cancer progression by suppressing STAT3 activity.
Xu J; Chen Y; Yang R; Zhou T; Ke W; Si Y; Yang S; Zhang T; Liu X; Zhang L; Xiang K; Guo Y; Liu Y
Arch Biochem Biophys; 2020 May; 684():108314. PubMed ID: 32088220
[TBL] [Abstract][Full Text] [Related]
55. STAT3 promotes peritoneal metastasis of gastric cancer by enhancing mesothelial-mesenchymal transition.
Yang H; Xu W
Biol Chem; 2021 May; 402(6):739-748. PubMed ID: 33711213
[TBL] [Abstract][Full Text] [Related]
56. Silencing of p68 and STAT3 synergistically diminishes cancer progression.
Hashemi V; Ahmadi A; Malakotikhah F; Chaleshtari MG; Baghi Moornani M; Masjedi A; Sojoodi M; Atyabi F; Nikkhoo A; Rostami N; Baradaran B; Azizi G; Yousefi B; Ghalamfarsa G; Jadidi-Niaragh F
Life Sci; 2020 May; 249():117499. PubMed ID: 32142763
[TBL] [Abstract][Full Text] [Related]
57. Silibinin inhibits proliferation, induces apoptosis and causes cell cycle arrest in human gastric cancer MGC803 cells via STAT3 pathway inhibition.
Wang YX; Cai H; Jiang G; Zhou TB; Wu H
Asian Pac J Cancer Prev; 2014; 15(16):6791-8. PubMed ID: 25169527
[TBL] [Abstract][Full Text] [Related]
58. SIRT6 inhibits growth of gastric cancer by inhibiting JAK2/STAT3 pathway.
Zhou J; Wu A; Yu X; Zhu J; Dai H
Oncol Rep; 2017 Aug; 38(2):1059-1066. PubMed ID: 28656307
[TBL] [Abstract][Full Text] [Related]
59. The Signal Transducer and Activator of Transcription 5B (STAT5B) Gene Promotes Proliferation and Drug Resistance of Human Mantle Cell Lymphoma Cells by Activating the Akt Signaling Pathway.
Zhang W; Liang X; Gong Y; Xiao C; Guo B; Yang T
Med Sci Monit; 2019 Apr; 25():2599-2608. PubMed ID: 30964854
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis.
Wu W; Takanashi M; Borjigin N; Ohno SI; Fujita K; Hoshino S; Osaka Y; Tsuchida A; Kuroda M
Br J Cancer; 2013 Feb; 108(3):653-61. PubMed ID: 23322197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
